# Charles M. Rudin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-m-rudin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 89,069 |
| Field | Lung Cancer Research Studies |
| h-index | 136 |
| i10-index | 452 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5049524331 |
| ORCID iD | 0000-0001-5204-3465 |
| Works | 1,712 |

## Researcher papers

Showing 12 of 39.

- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Tumor mutational load predicts survival after immunotherapy across multiple cancer types](https://scholariq.org/papers/tumor-mutational-load-predicts-survival-after-immunotherapy-across-multiple/)
- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Small-cell lung cancer](https://scholariq.org/papers/small-cell-lung-cancer/)
- [Akt Stimulates Aerobic Glycolysis in Cancer Cells](https://scholariq.org/papers/akt-stimulates-aerobic-glycolysis-in-cancer-cells/)
- [Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma](https://scholariq.org/papers/efficacy-and-safety-of-vismodegib-in-advanced-basal-cell-carcinoma/)
- [Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing](https://scholariq.org/papers/molecular-determinants-of-response-to-anti-programmed-cell-death-pd-1-and-anti/)
- [Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data](https://scholariq.org/papers/molecular-subtypes-of-small-cell-lung-cancer-a-synthesis-of-human-and-mouse/)
- [Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers](https://scholariq.org/papers/extracellular-vesicle-and-particle-biomarkers-define-multiple-human-cancers/)
- [Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy](https://scholariq.org/papers/pneumonitis-in-patients-treated-with-anti-programmed-death-1-programmed-death/)
- [Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer](https://scholariq.org/papers/genomic-features-of-response-to-combination-immunotherapy-in-patients-with/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.